SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

FSD Pharma Inc. – ‘20-F’ for 12/31/21 – ‘EX-1.1’

On:  Thursday, 3/31/22, at 8:09am ET   ·   For:  12/31/21   ·   Accession #:  1062993-22-9034   ·   File #:  1-39152

Previous ‘20-F’:  None   ·   Next:  ‘20-F’ on 3/31/23 for 12/31/22   ·   Latest:  ‘20-F’ on 4/2/24 for 12/31/23   ·   7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/31/22  FSD Pharma Inc.                   20-F       12/31/21  132:39M                                    Newsfile Corp./FA

Annual or Annual-Transition Report by a Foreign Non-Canadian Issuer   —   Form 20-F   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual or Annual-Transition Report by a Foreign     HTML   2.06M 
                Non-Canadian Issuer -- form20f                                   
 2: EX-1.1      Underwriting Agreement or Conflict Minerals Report  HTML     43K 
                -- exhibit1-1                                                    
 3: EX-2.1      Plan of Acquisition, Reorganization, Arrangement,   HTML     58K 
                Liquidation or Succession -- exhibit2-1                          
 9: EX-4.10     Instrument Defining the Rights of Security Holders  HTML     35K 
                -- exhibit4-10                                                   
10: EX-4.11     Instrument Defining the Rights of Security Holders  HTML     36K 
                -- exhibit4-11                                                   
11: EX-4.12     Instrument Defining the Rights of Security Holders  HTML     34K 
                -- exhibit4-12                                                   
12: EX-4.14     Instrument Defining the Rights of Security Holders  HTML     70K 
                -- exhibit4-14                                                   
13: EX-4.15     Instrument Defining the Rights of Security Holders  HTML     78K 
                -- exhibit4-15                                                   
14: EX-4.16     Instrument Defining the Rights of Security Holders  HTML     82K 
                -- exhibit4-16                                                   
15: EX-4.17     Instrument Defining the Rights of Security Holders  HTML     82K 
                -- exhibit4-17                                                   
 4: EX-4.2      Instrument Defining the Rights of Security Holders  HTML    251K 
                -- exhibit4-2                                                    
 5: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     33K 
                -- exhibit4-4                                                    
 6: EX-4.5      Instrument Defining the Rights of Security Holders  HTML     75K 
                -- exhibit4-5                                                    
 7: EX-4.6      Exhibit44.6                                         HTML     36K 
 8: EX-4.9      Instrument Defining the Rights of Security Holders  HTML     41K 
                -- exhibit4-9                                                    
16: EX-8.1      Opinion of Counsel re: Tax Matters -- exhibit8-1    HTML     33K 
19: EX-13.1     Annual or Quarterly Report to Security Holders --   HTML     35K 
                exhibit13-1                                                      
20: EX-13.2     Annual or Quarterly Report to Security Holders --   HTML     35K 
                exhibit13-2                                                      
22: EX-99.1     Miscellaneous Exhibit -- exhibit99-1                HTML     34K 
17: EX-12.1     Statement re: the Computation of Ratios --          HTML     37K 
                exhibit12-1                                                      
18: EX-12.2     Statement re: the Computation of Ratios --          HTML     37K 
                exhibit12-2                                                      
21: EX-15.1     Letter re: Unaudited Interim Financial Info --      HTML    359K 
                exhibit15-1                                                      
28: R1          Document And Entity Information                     HTML    116K 
29: R2          Consolidated Statements of Financial Position       HTML    107K 
30: R3          Consolidated Statements of Loss and Comprehensive   HTML     91K 
                Loss                                                             
31: R4          Consolidated Statements of Changes in               HTML     87K 
                Shareholder's Equity                                             
32: R5          Consolidated Statements of Cash Flows               HTML    116K 
33: R6          Nature of business                                  HTML     48K 
34: R7          Basis of presentation                               HTML     53K 
35: R8          Significant accounting policies                     HTML     81K 
36: R9          Acquisition of Prismic                              HTML     49K 
37: R10         Acquisition of Lucid                                HTML     50K 
38: R11         Assets held for sale                                HTML     99K 
39: R12         Other receivables                                   HTML     42K 
40: R13         Prepaid expenses and deposits                       HTML     42K 
41: R14         Investments                                         HTML     95K 
42: R15         Right-of-use asset                                  HTML     43K 
43: R16         Intangible assets                                   HTML     50K 
44: R17         Trade and other payables                            HTML     51K 
45: R18         Notes payable                                       HTML     43K 
46: R19         Lease obligations                                   HTML     52K 
47: R20         Warrants Liability                                  HTML     39K 
48: R21         Share capital                                       HTML    169K 
49: R22         Share-based compensation                            HTML    231K 
50: R23         Loss per share                                      HTML     44K 
51: R24         General and administrative                          HTML     53K 
52: R25         Income Taxes                                        HTML     66K 
53: R26         Commitments and contingencies                       HTML     56K 
54: R27         Related party transactions                          HTML     48K 
55: R28         Capital Management                                  HTML     38K 
56: R29         Financial Instruments and Risk Management           HTML     45K 
57: R30         Segmented information                               HTML     37K 
58: R31         Subsequent events                                   HTML     38K 
59: R32         Significant accounting policies (Policies)          HTML    109K 
60: R33         Nature of business (Tables)                         HTML     43K 
61: R34         Significant accounting policies (Tables)            HTML     40K 
62: R35         Acquisition of Prismic (Tables)                     HTML     49K 
63: R36         Acquisition of Lucid (Tables)                       HTML     48K 
64: R37         Assets held for sale (Tables)                       HTML     97K 
65: R38         Other receivables (Tables)                          HTML     42K 
66: R39         Prepaid expenses and deposits (Tables)              HTML     42K 
67: R40         Investments (Tables)                                HTML     85K 
68: R41         Right-of-use asset (Tables)                         HTML     42K 
69: R42         Intangible assets (Tables)                          HTML     48K 
70: R43         Trade and other payables (Tables)                   HTML     52K 
71: R44         Notes Payable (Tables)                              HTML     41K 
72: R45         Lease obligations (Tables)                          HTML     53K 
73: R46         Share capital (Tables)                              HTML    159K 
74: R47         Share-based compensation (Tables)                   HTML    234K 
75: R48         Loss per share (Tables)                             HTML     43K 
76: R49         General and administrative (Tables)                 HTML     52K 
77: R50         Income Taxes (Tables)                               HTML     69K 
78: R51         Related party transactions (Tables)                 HTML     43K 
79: R52         Nature of business - Schedule of ownership          HTML     51K 
                percentage in subsidiaries (Details)                             
80: R53         Significant accounting policies - Schedule of       HTML     55K 
                estimated useful lives of assets (Details)                       
81: R54         Acquisition of Prismic (Narrative) (Details)        HTML     51K 
82: R55         Acquisition of Prismic - Schedule of black scholes  HTML     78K 
                options pricing model (Details)                                  
83: R56         Acquisition of Prismic - Schedule of identifiable   HTML     50K 
                assets acquired and liabilities assumed (Details)                
84: R57         Acquisition of Lucid (Narrative) (Details)          HTML     56K 
85: R58         Acquisition of Lucid - Schedule of Black Scholes    HTML     77K 
                options pricing model (Details)                                  
86: R59         Acquisition of Lucid - Schedule of identifiable     HTML     49K 
                assets acquired and liabilities assumed (Details)                
87: R60         Assets held for sale (Narrative) (Details)          HTML     52K 
88: R61         Assets held for sale - Schedule of components of    HTML     39K 
                assets held for sale (Details)                                   
89: R62         Assets held for sale - Schedule of net loss and     HTML     77K 
                comprehensive loss from discontinued operations                  
                (Details)                                                        
90: R63         Assets held for sale - Schedule of cash flows from  HTML     75K 
                discontinued operations (Details)                                
91: R64         Other receivables - Schedule of other receivables   HTML     42K 
                (Details)                                                        
92: R65         Prepaid expenses and deposits - Schedule of         HTML     42K 
                prepaid expenses and deposits (Details)                          
93: R66         Investments (Narrative) (Details)                   HTML    206K 
94: R67         Investments - Schedule of investments (Details)     HTML     91K 
95: R68         Right-of-use asset (Narrative) (Details)            HTML     39K 
96: R69         Right-of-use asset - Schedule of right-of-use       HTML     45K 
                asset (Details)                                                  
97: R70         Intangible assets (Narrative) (Details)             HTML     52K 
98: R71         Intangible assets - Schedule of intangible assets   HTML     53K 
                (Details)                                                        
99: R72         Trade and other payables - Schedule of trade and    HTML     43K 
                other payables (Details)                                         
100: R73         Trade and other payables - Schedule of accrued      HTML     47K  
                liabilities (Details)                                            
101: R74         Notes Payable (Narrative) (Details)                 HTML     51K  
102: R75         Notes Payable - Schedule of notes payable           HTML     42K  
                (Details)                                                        
103: R76         Lease obligations - Schedule of lease obligations   HTML     49K  
                (Details)                                                        
104: R77         Lease obligations - Schedule of maturity analysis   HTML     48K  
                of operating lease payments (Details)                            
105: R78         Warrants Liability (Narrative) (Details)            HTML     72K  
106: R79         Share capital (Narrative) (Details)                 HTML    279K  
107: R80         Share capital - Schedule of reconciliation of the   HTML     89K  
                share capital (Details)                                          
108: R81         Share capital - Schedule of changes in number of    HTML     50K  
                warrants outstanding (Details)                                   
109: R82         Share capital - Schedule of fair value assumptions  HTML     52K  
                of warrants (Details)                                            
110: R83         Share capital - Schedule of warrants outstanding    HTML     95K  
                and exercise price (Details)                                     
111: R84         Share-based compensation (Narrative) (Details)      HTML     67K  
112: R85         Share-based compensation - Schedule of changes in   HTML     70K  
                number of share options (Details)                                
113: R86         Share-based compensation - Schedule of fair value   HTML     57K  
                assumptions of share options granted (Details)                   
114: R87         Share-based compensation - Schedule of exercise     HTML    216K  
                price and weighted average contractual term of                   
                share options outstanding and exercisable                        
                (Details)                                                        
115: R88         Share-based compensation - Schedule of share-based  HTML     47K  
                compensation (Details)                                           
116: R89         Loss per share - Schedule of loss per share         HTML     44K  
                (Details)                                                        
117: R90         General and administrative - Schedule of general    HTML     57K  
                and administrative expense (Details)                             
118: R91         Income Taxes (Narrative) (Details)                  HTML     41K  
119: R92         Income Taxes - Schedule of provision for income     HTML     53K  
                taxes (Details)                                                  
120: R93         Income Taxes - Schedule of deferred tax assets      HTML     40K  
                (Liabilities) (Details)                                          
121: R94         Income Taxes - Schedule of temporary differences    HTML     52K  
                for which deferred tax assets not recognised                     
                (Details)                                                        
122: R95         Income Taxes - Schedule of non-capital loss         HTML     43K  
                carryforwards (Details)                                          
123: R96         Commitments and contingencies (Narrative)           HTML     92K  
                (Details)                                                        
124: R97         Related party transactions (Narrative) (Details)    HTML     82K  
125: R98         Related party transactions - Schedule of key        HTML     42K  
                management personnel compensation (Details)                      
126: R99         Capital management (Narrative) (Details)            HTML     36K  
127: R100        Subsequent events (Narrative) (Details)             HTML     47K  
130: XML         IDEA XML File -- Filing Summary                      XML    223K  
128: XML         XBRL Instance -- form20f_htm                         XML   3.44M  
129: EXCEL       IDEA Workbook of Financial Reports                  XLSX    159K  
24: EX-101.CAL  XBRL Calculations -- huge-20211231_cal               XML    183K 
25: EX-101.DEF  XBRL Definitions -- huge-20211231_def                XML   1.17M 
26: EX-101.LAB  XBRL Labels -- huge-20211231_lab                     XML   4.85M 
27: EX-101.PRE  XBRL Presentations -- huge-20211231_pre              XML   1.53M 
23: EX-101.SCH  XBRL Schema -- huge-20211231                         XSD    613K 
131: JSON        XBRL Instance as JSON Data -- MetaLinks              490±   687K  
132: ZIP         XBRL Zipped Folder -- 0001062993-22-009034-xbrl      Zip    657K  


‘EX-1.1’   —   Underwriting Agreement or Conflict Minerals Report — exhibit1-1


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  FSD Pharma Inc.: Exhibit 1.1 - Filed by newsfilecorp.com  

 




 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 





 


 


 








 


 


 


 


 


 


 



 


 




 


 


 



2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/02/24  FSD Pharma Inc.                   20-F       12/31/23  120:15M                                    Blueprint/FA
 3/31/23  FSD Pharma Inc.                   20-F       12/31/22  119:14M                                    Newsfile Corp./FA


5 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/21/21  FSD Pharma Inc.                   6-K         9/21/21    4:674K                                   Business Wire/FA
 5/05/21  FSD Pharma Inc.                   6-K         5/14/21    3:914K                                   Newsfile Corp./FA
 2/11/21  FSD Pharma Inc.                   6-K         2/11/21    2:217K                                   Newsfile Corp./FA
 3/18/20  FSD Pharma Inc.                   6-K         3/18/20    2:17M                                    Newsfile Corp./FA
12/06/19  FSD Pharma Inc.                   40FR12B               52:25M                                    Newsfile Corp./FA
Top
Filing Submission 0001062993-22-009034   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 12:17:45.1am ET